Trials / Unknown
UnknownNCT04824495
Evaluation of Inflammatory Cytokines During COVID-19
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The aim of this study is to evaluate pro-inflammatory cytokines as well as microvesicles during the course of SARS-CoV2 infection in the context of clinical parameters.
Detailed description
In this prospective trial, 100 patients with an acute SARS-CoV2 infection are enrolled. After confirmation of COVID-19, blood samples are taken for evaluation of various inflammatory cyokines and microvesicles at day 1, 5, 9 and 13 during hospitalisation and are interpreted in the context of clinical parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood sample | Blood samples at different timepoints during SARS-CoV2 infection |
Timeline
- Start date
- 2021-01-07
- Primary completion
- 2021-08-31
- Completion
- 2021-12-31
- First posted
- 2021-04-01
- Last updated
- 2021-04-06
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04824495. Inclusion in this directory is not an endorsement.